A Multi-Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation b.i.d Dosing in Children Aged 2 to 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Trial Profile

A Multi-Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation b.i.d Dosing in Children Aged 2 to 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions
  • Acronyms PAL
  • Sponsors UCB
  • Most Recent Events

    • 09 Sep 2009 Actual patient number (173) added as reported by ClinicalTrials.gov.
    • 16 Jul 2008 Patient numbers amended from 150 to 155 as reported by ClinicalTrials.gov.
    • 16 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top